Skip to main content
TipRanks
Go Ultimate75% OFF

Ron Ellis Insider Profile

4 Followers

Ron Ellis, former President & CEO, Director at Endocyte, holds 330.95K shares in Endocyte (Ticker: ECYT).

Ron Ellis's Trading History

ECYT
Endocyte
Jun 28, 2016―Uninformative Sell49.78K$7.94M
ECYT
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 28, 2016Uninformative Sell$49.78K13,528$3.68―
Feb 08, 2016Uninformative Sell$16.85K5,405$3.11―
Feb 08, 2016Uninformative Buy$0.0026,875$0.00―
Feb 26, 2015Informative Buy$272.77K52,356$5.21-48.30%
Feb 06, 2015Uninformative Buy$0.0026,875$0.00―

You May Also Like

Ron Ellis insider profile FAQ

What is the percentage of profitable transactions made by Ron Ellis?
The percentage of profitable transactions made by Ron Ellis is 0%.
What is the average return per transaction made by Ron Ellis?
The average return per transaction made by Ron Ellis is -37.40%.
What stocks does Ron Ellis hold?
Ron Ellis holds: ECYT stocks.
What was Ron Ellis’s latest transaction?
Ron Ellis’s latest transaction was an Uninformative Sell of $49.78K.
What was Ron Ellis's most profitable transaction?
Ron Ellis’s most profitable transaction was an Informative Buy of ECYT stock on November 7, 2014. The return on the trade was -11.20%.
What is Ron Ellis's role in Endocyte?
Ron Ellis's role in Endocyte is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.